Assay configuration and analytic specificity may have major effects on prediction of clinical outcomes - Implications for reference standards

Clinical Chemistry

Volumn 55, Issue 5, 2009, Pages 848-849

  Klee, George G ^a,b  

^a MAYO CLINIC   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOPONTIN; PROSTATE SPECIFIC ANTIGEN; TROPONIN C; TROPONIN I; TROPONIN T;

CANCER SURVIVAL; EDITORIAL; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PROGNOSIS; PROSTATE CANCER; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY;

DIAGNOSTIC TECHNIQUES AND PROCEDURES; HUMANS; REFERENCE STANDARDS; SENSITIVITY AND SPECIFICITY;

EID: 66049107652     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2009.124172     Document Type: Editorial

References (10)

1. Anborgh PH, Wilson SM, Tuck AB, Winquist E, Schmidt N, Hart R, et al. New dual monoclonal ELISA for measuring plasma osteopontin as a biomarker associated with survival in prostate cancer: clinical validation and comparison of multiple ELISAs. Clin Chem 2009;55:895-903.
2. Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices. L331. Off J Eur Communities 1998;41:1-37.
3. Dati F. The new European directive on in vitro diagnostics. Clin Chem Lab Med 2003;41:1289-1298 (Pubitemid 37266116)
4. Bureau International des Poids et Mesures. JCTLM: Joint Committee for Traceability in Laboratory Medicine. http://www.bipm.org/en/committees/jc/jctlm/ (Accessed February 2009).
5. International Organization for Standardization (ISO). In vitro diagnostic medical devices - measurement of quantities in biological samples - metrological traceability of values assigned to calibrators and control materials. ISO 17511:2003. Geneva: ISO; 2003. 23 p.
6. International Organization for Standardization (ISO). In vitro diagnostic medical devices - measurement of quantities in samples of biological origin - description of reference materials. ISO 15194:2002. Geneva: ISO; 2002. 14 p.
7. National Institute of Standards & Technology. Standard Reference Material 2921: human cardiac troponin complex. http://ts.nist.gov/ MeasurementServices/ ReferenceMaterials/archived-certificates/ 2921%20Human%20Cardiac% 20Troponin%20Complex,%20April%2030,%202004.pdf (Accessed February 2009). 8 p. Certificate of analysis.
8. Bunk DM, Welch MJ. Characterization of a new certified reference material for human cardiac troponin I. Clin Chem 2006;52:212-219 (Pubitemid 43185481)
9. Fortin T, Salvador A, Charrier J-P, Lenz C, Lacoux X, Morla A, et al. Clinical quantitation of prostate specific antigen biomarker in the low nanogram/mL range by conventional bore liquid chromatography-tandem mass spectrometry (MRM) coupling and correlation with ELISA tests. Mol Cell Proteomics. [Epub ahead of print 2008 Dec 8].
10. Christensen B, Petersen TE, Sorensen ES. Post-translational modification and proteolytic processing of urinary osteopontin. Biochem J 2008;411:53-61.